DSE : ASIATICLAB

Asiatic Laboratories Limited — Key statistics

Pharmaceutical Preparations · Bangladesh

Last price 108 BDT (At close: Oct 29, 2026) · Market cap 13.22B

Latest research: Asiatic Laboratories financial analysis: 9M FY26 sales +99%, IPO funds unused, lock-in extended (Oct 2026) · Asiatic Laboratories: sales doubled in 9M FY2026 after a debt-funded plant upgrade, while 68% of the IPO money sat unused at June 2025

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Key statistics

Valuation

MeasureValue
Market Cap13.22B
Enterprise Value14.77B

Dates

MeasureValue
Earnings DateNov 5, 2026
Ex-Dividend DateNov 23, 2025

Shares

MeasureValue
Current Share Class122.39M
Shares Outstanding122.39M
Shares Change (YoY)+23.77%
Shares Change (QoQ)n/a
Owned by Insiders (%)40.71%
Owned by Institutions (%)n/a
Float72.56M

Ratios

MeasureValue
PE Ratio24.88
Forward PEn/a
PS Ratio4.55
PB Ratio1.88
P/TBV Ratio1.88
P/FCF Ration/a
P/OCF Ratio19.08
PEG Ration/a

Evratios

MeasureValue
EV / Earnings27.81
EV / Sales5.09
EV / EBITDA12.70
EV / EBIT14.96
EV / FCFn/a

Financialposition

MeasureValue
Current Ratio4.27
Quick Ratio1.47
Debt / Equity0.22
Debt / EBITDA1.36
Debt / FCFn/a
Interest Coverage3.26

Financialefficiency

MeasureValue
Return on Equity (ROE)n/a
Return on Assets (ROA)n/a
Return on Invested Capital (ROIC)9.08%
Return on Capital Employed (ROCE)10.88%
Weighted Average Cost of Capital (WACC)8.19%
Revenue Per Employee3.94M
Profits Per Employee720,966
Employee Count737
Asset Turnovern/a
Inventory Turnovern/a

Taxes

MeasureValue
Income Tax155.81M
Effective Tax Rate22.67%

Stockprice

MeasureValue
Beta (5Y)0.52
52-Week Price Change+88.48%
50-Day Moving Average108.00
200-Day Moving Average97.70
Relative Strength Index (RSI)52.35
Average Volume (20 Days)517,632

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenue2.90B
Gross Profit1.30B
Operating Income987.81M
Pretax Income687.17M
Net Income531.35M
EBITDA1.15B
EBIT987.81M
Earnings Per Share (EPS)4.34

Balancesheet

MeasureValue
Cash & Cash Equivalents22.15M
Total Debt1.58B
Net Cash-1.56B
Net Cash Per Share-12.71
Equity (Book Value)7.03B
Book Value Per Share57.46
Working Capital1.85B

Cashflow

MeasureValue
Operating Cash Flow692.80M
Capital Expenditures-983.03M
Depreciation & Amortization162.41M
Net Borrowing656.09M
Free Cash Flow-290.23M
FCF Per Share-2.37

Margins

MeasureValue
Gross Margin44.72%
Operating Margin34.00%
Pretax Margin23.66%
Profit Margin18.29%
EBITDA Margin39.60%
EBIT Margin34.00%
FCF Marginn/a

Dividends

MeasureValue
Dividend Per Share1.00
Dividend Yield0.93%
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ratio10.53%
FCF Payout Ration/a
Buyback Yield-23.77%
Shareholder Yield-22.84%
Earnings Yield4.02%
FCF Yield-2.20%

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Score2.8
Piotroski F-Score4

Fairvalue

MeasureValue
Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Number
Graham Upside